•  
  •  
  •  
  •  

2025-10-08 18:51:36

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • ppeks
  • koesss
  • kentosss
  • kentosss
  • kentosss

Keywords Selected:  INE485C01011

Stock Report

  • EDQM issues CEP Certificate for IOL Chemicals and Pharmaceuticals Ltd's API Quetiapine Fumarate
  • EDQM issued CEP Certificate for MESALAZINE
  • IOL Chemicals and Pharmaceuticals Ltd board approves 5 For 1 Stock Split
  • Indian Chemical Council awarded Responsible CareĀ® Logo to IOL Chemicals and Pharmaceuticals Ltd
  • EDQM issues CEP certificate to IOL Chemicals and Pharmaceuticals Ltd for Valsartan
  • NMPA, China approves Fenofibrate manufactured by IOL Chemicals and Pharmaceuticals Ltd
  • IOL Chemicals and Pharmaceuticals Ltd receives EDQM CEP certificate for Allopurinol
  • IOL Chemicals and Pharmaceuticals Ltd receives GMP Certificate issued by Brazilian Health Regulatory Agency ANVISA
  • IOL Chemicals and Pharmaceuticals Ltd successfully completes ANVISA GMP audit
  • IOL Chemicals and Pharmaceuticals Ltd's product approved by CDE of NMPA, China
  • IOL Chemicals and Pharmaceuticals Ltd rating reaffirmed to A+ by CARE Ratings
  • IOL Chemicals and Pharmaceuticals Ltd's Acetic Anhydride Plant goes on stream
  • IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to Export in European Market
  • IOL Chemicals and Pharmaceuticals appoints Vikas Vij as CEO
  • IOL Chemicals and Pharmaceuticals Limited announces board rejig
  • IOL Chemicals and Pharmaceuticals Ltd declares interim dividend of Rs. 4
  • IOL Chemicals and Pharmaceuticals Ltd receives EUGMP certification from Hungary authorities
  • IOL Chemicals and Pharmaceuticals Ltd receives patent
  • IOL Chemicals and Pharmaceuticals Ltd gets EDQM nod for Levetiracetam
  • IOL Chemicals and Pharmaceuticals Ltd commences commercial production of Paracetamol
  • IOL Chemicals and Pharmaceuticals Ltd declares interim dividend of Rs. 4
  • IOL Chemicals & Pharmaceuticals Ltd receives Korean FDA approval

Latest Post

  • ppeks
  • koesss
  • kentosss
  • kentosss
  • kentosss


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024